Phase III Multicenter Placebo-Controlled Study of Tamsulosin in Benign Prostatic Hyperplasia - a randomized, controlled trial in patients with benign prostatic 'obstruction' (symptomatic BPH)

By Lepor H.  

Urology, Vol. 51, Iss. 6, 1998-06 ,pp. : 892-900

Elsevier

Access to resources Recommend Favorite

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia

By Elhilali M.M.   Ramsey E.W.   Barkin J.   Casey R.W.   Boake R.C.   Beland G.   Fradet Y.   Trachtenberg J.   Orovan W.L.   Schick E.   Klotz L.H.  

Urology, Vol. 47, Iss. 3, 1996-03 ,pp. : 335-342

Elsevier

Access to resources Recommend Favorite

Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study

By Maria G.   Brisinda G.   Civello I.M.   Bentivoglio A.R.   Sganga G.   Albanese A.  

Urology, Vol. 62, Iss. 2, 2003-08 ,pp. : 259-264

Elsevier

Access to resources Recommend Favorite

Reproducibility of uroflow measurement: experience during a double-blind, placebo-controlled study of doxazosin in benign prostatic hyperplasia

By Feneley M.R.   Dunsmuir W.D.   Pearce J.   Kirby R.S.  

Urology, Vol. 47, Iss. 5, 1996-05 ,pp. : 658-663

Elsevier

Access to resources Recommend Favorite

Effects of finasteride and cyproterone acetate on hematuria associated with benign prostatic hyperplasia: a prospective, randomized, controlled study

By Perimenis P.   Gyftopoulos K.   Markou S.   Barbalias G.  

Urology, Vol. 59, Iss. 3, 2002-03 ,pp. : 373-377

Elsevier

Access to resources Recommend Favorite